If GLP-1 drugs prove effective in reducing cravings or reshaping reward response, they could become part of a broader toolkit for addressing: Alcohol use disorder Nicotine dependence Stimulant addiction Binge eating disorder Impulse control disorders However, experts emphasize that GLP-1 medications are not a stand-alone cure for addiction
One of the most promising drug classes in recent years is GLP-1 receptor agonists, including semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro).These medications have revolutionized weight loss and diabetes management, with additional potential benefits in reducing risks for conditions like sleep apnea, cardiovascular disease, and even alcohol dependence
For one, some compounding pharmacies use semaglutide acetate, which is a semaglutide salt that doesnt meet FDA guidelines
Patients taking insulin or sulfonylureas should be monitored for hypoglycemia risk
Monpellier, V
Glucokinase Activators Glucokinase is an enzyme that acts as a glucose sensor, primarily in the pancreas and liver